Gold mediated sp³αC-H functionalization of steroidal diglycoside and their anti-cancer evaluation

References

• Casi G, Huguenin-Dezot N, Zuberbühler K, Scheuermann J, Neri D. 2012. Site-specific traceless coupling of potent cytotoxic drugs to recombinant antibodies for pharmacodelivery. J Am Chem Soc. 134(13):5887–5892.
   PubMed Web of Science ®Google Scholar
• Charifson PS, Walters WP. 2014. Acidic and basic drugs in medicinal chemistry: a perspective. J Med Chem. 57(23):9701–9717.
   PubMed Web of Science ®Google Scholar
• Dangel BD, Godula K, Youn SW, Sezen B, Sames D. 2002. C − C bond formation via C − H bond activation: synthesis of the core of teleocidin B4. J Am Chem Soc. 124(40):11856–11857.
   PubMed Web of Science ®Google Scholar
• David SE, Timmins P, Conway BR. 2012. Impact of the counterion on the solubility and physicochemical properties of salts of carboxylic acid drugs. Drug Dev Ind Pharm. 38(1):93–103.
   PubMed Web of Science ®Google Scholar
• Fernández-Herrera MA, López-Muñoz H, Hernández-Vázquez JMV, Sánchez-Sánchez L, Escobar-Sánchez ML, Pinto BM, Sandoval-Ramírez J. 2012. Synthesis and selective anticancer activity of steroidal glycoconjugates. Eur J Med Chem. 54:721–727.
   PubMed Web of Science ®Google Scholar
• Fiori KW, Du Bois J. 2007. Catalytic intermolecular amination of C−H bonds: method development and mechanistic insights. J Am Chem Soc. 129(3):562–568.
   PubMed Web of Science ®Google Scholar
• Gaillard S, Cazin CSJ, Nolan SP. 2012. N-heterocyclic carbene gold(I) and copper(I) complexes in C–H bond activation. Acc Chem Res. 45(6):778–787.
   PubMed Web of Science ®Google Scholar
• Gatineau D, Goddard J-P, Mouriès-Mansuy V, Fensterbank L. 2013. When NHC ligands make a difference in gold catalysis. Isr J Chem. 53(11-12):892–900.
   Web of Science ®Google Scholar
• Gorin DJ, Toste FD. 2007. Relativistic effects in homogeneous gold catalysis. Nature. 446(7134):395–403.
   PubMed Web of Science ®Google Scholar
• Graffner-Nordberg M, Kolmodin K, Åqvist J, Queener SF, Hallberg A. 2001. Design, synthesis, computational prediction, and biological evaluation of ester soft drugs as inhibitors of dihydrofolate reductase from Pneumocystis carinii. J Med Chem. 44(15):2391–2402.
   PubMed Web of Science ®Google Scholar
• Grishkovets VI, Karpov PA, Iksanova SV, Chirva VY. 1998. A steroid glycoside from the seeds of Yucca macrocarpa. Chem Nat Compd. 34(6):738–740.
   Google Scholar
• Guerrieri P, Rumondor AC, Li T, Taylor LS. 2010. Analysis of relationships between solid-state properties, counterion, and developability of pharmaceutical salts. AAPS Pharm Sci Tech. 11(3):1212–1222.
   PubMed Web of Science ®Google Scholar
• Hoffmann-Röder A, Krause N. 2005. The golden gate to catalysis. Org Biomol Chem. 3(3):387–391.
   PubMed Web of Science ®Google Scholar
• Hopkinson MN, Richter C, Schedler M, Glorius F. 2014. An overview of N-heterocyclic carbenes. Nature. 510(7506):485–496.
   PubMed Web of Science ®Google Scholar
• Huang Z, Velázquez CA, Abdellatif KRA, Chowdhury MA, Reisz JA, DuMond JF, King SB, Knaus EE. 2011. Ethanesulfohydroxamic acid ester prodrugs of nonsteroidal anti-inflammatory drugs (NSAIDs): synthesis, nitric oxide and nitroxyl release, cyclooxygenase inhibition, anti-inflammatory, and ulcerogenicity index studies. J Med Chem. 54(5):1356–1364.
   PubMed Web of Science ®Google Scholar
• Hubbert C, Hashmi A. 2012. Gold-catalyzed aldol and related reactions In: Stephen A, Hashmi K, Dean Toste F, editors. Modern gold catalyzed synthesis. Weinheim (Germany): Wiley-VCH.
   Google Scholar
• Huttunen KM, Raunio H, Rautio J. 2011. Prodrugs–from serendipity to rational design. Pharmacol Rev. 63(3):750–771.
   PubMed Web of Science ®Google Scholar
• Hwang S-K, Juhasz A, Yoon S-H, Bodor N. 2000. Soft drugs. 12. Design, synthesis, and evaluation of soft bufuralol analogues. J Med Chem. 43(8):1525–1532.
   PubMed Web of Science ®Google Scholar
• Insaf SS, Witiak DT. 1999. Facile non-racemizing route for the N-alkylation of hindered secondary amines. Synthesis. 3:435–440.
   Google Scholar
• Jones CJ, Taube D, Ziatdinov VR, Periana RA, Nielsen RJ, Oxgaard J, Goddard WA, III. 2004. Selective oxidation of methane to methanol catalyzed, with C-H activation, by homogeneous, cationic gold. Angew Chem Int Ed. 43(35):4626–4629.
   PubMed Web of Science ®Google Scholar
• Kankala S, Kankala RK, Kommidi DR, Mudithanapelli C, Balaboina R, Vadde R, Jonnalagadda SB, Vasam CS. 2014. Synthesis and anti-cancer evaluation of steroidal diglycoside–pyrazoline hybrids. RSC Adv. 4(76):40305–40311.
   Web of Science ®Google Scholar
• Kaufmann AM, Krise JP. 2007. Lysosomal sequestration of amine-containing drugs: analysis and therapeutic implications. J Pharm Sci. 96(4):729–746.
   PubMed Web of Science ®Google Scholar
• Koehn FE, Carter GT. 2005. The evolving role of natural products in drug discovery. Nat Rev Drug Discov. 4(3):206–220.
   PubMed Web of Science ®Google Scholar
• Korn C, Balbach S. 2014. Compound selection for development—is salt formation the ultimate answer? Experiences with an extended concept of the “100 mg approach”. Eur J Pharm Sci. 57:257–263.
   PubMed Web of Science ®Google Scholar
• Lazar C, Kluczyk A, Kiyota T, Konishi Y. 2004. Drug evolution concept in drug design: 1. Hybridization method. J Med Chem. 47(27):6973–6982.
   PubMed Web of Science ®Google Scholar
• Lein M, Rudolph M, Hashmi SK, Schwerdtfeger P. 2010. Homogeneous gold catalysis: mechanism and relativistic effects of the addition of water to propyne. Organometallics. 29(10):2206–2210.
   Web of Science ®Google Scholar
• Lewis CA, Longcore KE, Miller SJ, Wender PA. 2009. An approach to the site-selective diversification of apoptolidin A with peptide-based catalysts. J Nat Prod. 72(10):1864–1869.
   PubMed Web of Science ®Google Scholar
• Li J, Cisar JS, Zhou CY, Vera B, Williams H, Rodríguez AD, Cravatt BF, Romo D. 2013. Simultaneous structure-activity studies and arming of natural products by C–H amination reveal cellular targets of eupalmerin acetate. Nature Chem. 5(6):510–517.
   PubMed Web of Science ®Google Scholar
• Lin IJB, Vasam CS. 2005. Review of gold(I) N-heterocyclic carbenes. Can J Chem. 83(6-7):812–825.
   Web of Science ®Google Scholar
• López-Iglesias B, Pérez C, Morales-García JA, Alonso-Gil S, Pérez-Castillo A, Romero A, López MG, Villarroya M, Conde S, Rodríguez-Franco MI. 2014. New melatonin–N,N-dibenzyl(N-methyl)amine hybrids: potent neurogenic agents with antioxidant, cholinergic, and neuroprotective properties as innovative drugs for Alzheimer’s disease. J Med Chem. 57(9):3773–3785.
   PubMed Web of Science ®Google Scholar
• Mahy J-P, Ciesielski J, Dauban P. 2014. Catalytic C-H amination: a reaction now accessible to engineered natural enzymes. Angew Chem Int Ed. 53(27):6862–6864.
   PubMed Web of Science ®Google Scholar
• Marion N, Nolan SP. 2010. N-heterocyclic carbenes in gold catalysis. Chem Soc Rev. 37(9):1776–1782.
   Web of Science ®Google Scholar
• Morán-Poladura P, Rubio E, González JM. 2015. Intramolecular C-H activation through gold(I)-catalyzed reaction of iodoalkynes. Angew Chem Int Ed. 54(10):3052–3055.
   PubMed Web of Science ®Google Scholar
• Nelson DJ, Nolan SP. 2014. N-heterocyclic carbenes. In: Steven P. Nolan, editor. N-heterocyclic carbenes: effective tools for organometallic synthesis. Weinheim (Germany): Wiley-VCH.
   Google Scholar
• Rigo MVR, Allemandi DA, Manzo RH. 2004. A linear free energy relationship treatment of the affinity between carboxymethylcellulose and basic drugs. Mol Pharmaceut. 1:383–386.
   PubMed Web of Science ®Google Scholar
• Robles O, Romo D. 2014. Chemo- and site-selective derivatizations of natural products enabling biological studies. Nat Prod Rep. 31(3):318–334.
   PubMed Web of Science ®Google Scholar
• Salvatore RN, Yoon CH, Jung KW. 2001. Synthesis of secondary amines. Tetrahedron 57(37):7785–7998.
   Web of Science ®Google Scholar
• Serajuddin ATM. 2007. Salt formation to improve drug solubility. Adv Drug Deliv Rev. 59(7):603–616.
   PubMed Web of Science ®Google Scholar
• Testa B, Mayer JM. 2006. The hydrolysis of amides. In: Hydrolysis in drug and prodrug metabolism. Weinheim (Germany): Wiley-VCH; p. 81–162. Verlag Helvetica Chimica Acta.
   Google Scholar
• Wencel-Delord J, Glorius F. 2013. C-H bond activation enables the rapid construction and late-stage diversification of functional molecules. Nature Chem. 5(5):369–375.
   PubMed Web of Science ®Google Scholar
• Wender PA, Hilinski MK, Mayweg AVW. 2005. Late-stage intermolecular CH activation for lead diversification: a highly chemoselective oxyfunctionalization of the C-9 position of potent bryostatin analogues. Org Lett. 7(1):79–82.
   PubMed Web of Science ®Google Scholar
• Xie J, Pan C, Abdukader A, Zhu C. 2014. Gold-catalyzed C(sp3)–H bond functionalization. Chem Soc Rev. 43(15):5245–5256.
   PubMed Web of Science ®Google Scholar
• Yamaguchi J, Yamaguchi AD, Itami K. 2012. C-H bond functionalization: emerging synthetic tools for natural products and pharmaceuticals. Angew Chem Int Ed. 51(36):8960–9009.
   PubMed Web of Science ®Google Scholar
• Yao X, Li C-J. 2004. Highly efficient addition of activated methylene compounds to alkenes catalyzed by gold and silver. J Am Chem Soc. 126(22):6884–6885.
   PubMed Web of Science ®Google Scholar
• Zalatan DN, Du Bois J. 2009. Understanding the differential performance of Rh2(esp)2 as a catalyst for C − H amination. J Am Chem Soc. 131(22):7558–7559.
   PubMed Web of Science ®Google Scholar
• Zatolochnaya OV, Gevorgyan V. 2014. C-H activation: the road less travelled to amination. Nature Chem. 6(8):661–663.
   PubMed Web of Science ®Google Scholar
• Zhang J, Ponomareva LV, Nandurkar NS, Yuan Y, Fang L, Zhan C-G, Thorson JS. 2015. Influence of sugar amine regiochemistry on digitoxigenin neoglycoside anticancer activity. ACS Med Chem Lett. 6(10):1053–1058.
   PubMed Web of Science ®Google Scholar
• Zhou C-Y, Li J, Peddibhotla S, Romo D. 2010. Mild arming and derivatization of natural products via an In(OTf)3-catalyzed arene iodination. Org Lett. 12(9):2104–2107.
   PubMed Web of Science ®Google Scholar